$484.83
▲ $6.12 (+1.3%)
VRTX
Vertex Pharmaceuticals
Health Care
Investor Score
65B-
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
61
Technical
79
Fundamental
76
Growth
38
Fair Value
100
News
42
Quality
56
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.